Jan 05,2024

Solera Health Expands Platform for Virtual Specialty Care Including Diabetes Care from 9amHealth

Solera Health, a technology company, has expanded its HALO Platform to include virtual specialty care. Its new HALO Platform — which was launched in October — helps customers manage all of their contracted point solutions in one place, whether they’re part of Solera’s network or their own contracted solutions. The new virtual specialty care offering on the Halo Platform is supported in partnership with 9amHealth, Vori Health and Oshi Health. San Diego, California-based 9amHealth offers cardiometabolic care for those with diabetes, obesity and co-conditions. Vori Health support those with back or joint pain, and Oshi Health offers a virtual digestive health center for gastrointestinal conditions. Other companies in Solera’s network that are on the Halo Platform include WeightWatchers for weight management, Sword Health for musculoskeletal conditions and Headspace for mental health. By offering virtual specialty care services on the Halo Platform, Solera ultimately aims to “serve as an integrator for a fractured, inefficient health system and experience — creating a new entry point into the care continuum at a lower cost,” said Ed Liebowitz, chief product officer of Solera Health.

COLLABORATION PARTNERSHIP

#institution

#virtual care

View Analyst & Ambassador Comments
Go to original news
Dec 26,2023 TOP STORY

Carrum Health, Florida Cancer Institute partner to expand breast cancer care

Carrum Health, a digital marketplace for employers to purchase bundled healthcare services, announced it has partnered with Florida Cancer Specialists & Research Institute to offer employers in Florida breast cancer care services. Carrum Health offers a value-based platform that allows self-funded employers to buy specialty care, focusing on surgical and cancer care. It provides a digital platform that gives patients access to a care specialist who guides them through the surgical process and employers a platform for navigating Carrum's network. Through the partnership, patients with non-metastatic breast cancer with employers utilizing Carrum Health can access two years of breast cancer treatment at nearly 100 FCS locations, including radiation, symptom management and chemotherapy.

COLLABORATION PARTNERSHIP

#institution

#virtual care

View Analyst & Ambassador Comments
Go to original news
Dec 20,2023

Bicêtre AP-HP Hospital Integrates AI Solution from Owkin to Improve the Prediction of Breast Cancer Relapses

Owkin announces a new collaboration with Bicêtre AP-HP Hospital, putting artificial intelligence at the service of oncology diagnosis. The Bicêtre AP-HP Hospital, a pilot in digital pathology, is now positioning itself as a pioneer by using RlapsRisk® BC, an innovative AI solution designed to help doctors assess the risk of relapse of patients suffering from cancer of the breast. This AI diagnostic technology, developed by Owkin, helps assess the relapse risk of early-stage breast cancer patients after tumor surgery, allowing oncologists to determine which high-risk patients may benefit from targeted therapies and which low-risk patients can potentially avoid chemotherapy. This initiative fully supports the ten-year national strategy to combat cancer, by providing healthcare professionals with the cutting-edge tools necessary to improve patient care. With this partnership, Owkin strengthens its commitment to public hospitals in France.

COLLABORATION PARTNERSHIP

#institution

#ai/software

#clinical decision support

View Analyst & Ambassador Comments
Go to original news
Dec 20,2023 TOP STORY

Owkin and Cerba Path collaborate to transform breast and colorectal cancer diagnosis through integration of artificial intelligence-powered tests into standard clinical practice

Owkin and Cerba Path, the Cerba HealthCare’s network of pathologists, announced a new partnership. The two companies will work together to integrate Owkin’s cutting-edge AI-driven diagnostics into Cerba Path’s routine digital workflows and further validate AI-based tools for precision medicine. Owkin’s AI diagnostics will benefit from Cerba Path’s fully digitized workflow and be able to reach a broader audience of pathologists who can access the Cerba Path platform remotely from any location in France. Owkin’s AI diagnostic offering includes MSIntuit® CRC, the first CE-marked diagnostic that optimizes testing for microsatellite instability with routine H&E slides, and is developing RlapsRisk® BC, a risk assessment tool for recurrence in early breast cancer.

COLLABORATION PARTNERSHIP

#institution

#ai/software

#clinical decision support

View Analyst & Ambassador Comments
Go to original news
Dec 19,2023

CMS Funded Study Shows Great Promise for Indiana-Based American Senior Communities

American Senior Communities (ASC), based in Indiana, has partnered with Mynd Immersive to combat isolation and loneliness among aging residents through a CMS-funded program implemented in 15 skilled nursing facilities. Launched in August 2023, the initiative aimed to improve overall quality of life, particularly by addressing isolation, with a target of 60% increased socialization. Initial outcomes reported to CMS and the Indiana Department of Health surpassed expectations, with 88% success in reducing isolation, an 88% improvement in socialization, and 91% of residents using VR recommending it to others. Mynd Immersive offers a range of interactive experiences to enhance emotional, physical, behavioral, cognitive, and spiritual health for the aging population. ASC emphasizes the positive impact on both staff and residents, highlighting the scalability and cost-effectiveness of deploying Mynd across multiple communities. Mynd Immersive also collaborated with Stanford University on a study exploring the positive relationship impact between older adults and caregivers using its platform.

COLLABORATION PARTNERSHIP

#institution

#virtual reality

View Analyst & Ambassador Comments
Go to original news
Dec 11,2023

Lunit Advances to Stage 2 of Australia's National Breast Cancer Screening Project

Lunit announced its progression to the second stage of the BreastScreen NSW (BSNSW) Machine Reading Solution Project. BSNSW, a key part of the national BreastScreen Australia Program, is a joint initiative funded by the Commonwealth, state and territory governments, and managed by the Cancer Institute NSW. The program’s primary objective is to enhance the survival rates of women diagnosed with breast cancer by facilitating early detection. Last year, Lunit INSIGHT MMG, Lunit's AI-powered mammography analysis solution, was selected as the preferred AI technology for mammogram screening in the BSNSW State program. The project's first stage validated the accuracy and clinical benefits of Lunit INSIGHT MMG, where approximately 650,000 mammograms were analyzed against historical reports delivered by BSNSW radiologists. In the upcoming Stage 2, Lunit INSIGHT MMG will undergo a prospective validation in the intended production workflow. An estimated 200,000 exams will be assessed over six months, with the system shadowing radiologist reads across the duration of the stage. This project stage will also include evaluations of Lunit’s recently FDA-cleared Lunit INSIGHT DBT, an AI solution for 3D breast tomosynthesis.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Nov 29,2023

Qure to Boost Global Healthcare with Advanced AI Integration

Qure.ai announces its collaboration with GE HealthCare. This collaboration aims to bringing the power of AI-driven healthcare to medical professionals and patients alike. Qure's AI solution, known for its seamless integration and improving diagnostic capabilities of radiology departments, will comprehensively cater to a range of care areas including stroke, lung cancer, early indications of heart failure, and intensive care and emergency care cases. Qure's AI, seamlessly integrated into the GE HealthCare’s App Orchestrator platform, promises streamlined workflows and optimized resource utilization. The platform will enable healthcare providers to access Qure’s flagship products; qXR – AI enabled chest X-ray solution and qER – AI enabled head CT solution for use cases like ICU settings, and preliminary reporting of normal-abnormal reports with increased speed and accuracy.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Dec 06,2023 TOP STORY

NHS Greater Glasgow and Clyde deploys multi-site AI for earlier detection of lung cancer

A digital health collaboration consisting of The Scottish Government, University of Glasgow, Qure.ai and NHS Greater Glasgow and Clyde (NHSGGC) is rolling out the AI-powered chest X-ray reporting solution, qXR, across Glasgow, for approximately 70,000 chest X-rays per year. The aim is to detect lung cancer earlier to improve patient survival. It is part of a national coordinated evaluation of Artificial Intelligence (AI) in radiology to improve patient outcomes, plus prove clinical and cost effectiveness. qXR is being supported by the University of Glasgow’s Digital Health Validation Lab, part of the Living Laboratory for Precision Medicine, providing academic leadership and support to deliver the trial alongside NHSGGC and Qure.ai.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Dec 05,2023

PCMIS Health Technologies Contracted to Support Silvercloud® By Amwell® Delivery of National Digital Mental Health Program for Ireland

PCMIS Health Technologies’ patient record system will provide effective, evidence-based case and risk management and outcome monitoring through a seamless integration with SilverCloud by Amwell. In addition, PCMIS will facilitate comprehensive national reporting as part of the next phase of the SilverCloud and Ireland Health Service Executive (HSE) partnership. PCMIS and Amwell have a history of collaboration and integration, having been the first to offer a “Digital First” referral and treatment pathway for NHS England Talking Therapies services in 2019. This is the first time the companies have worked together on a national health programme and as such, marks a new phase in their integrated approach to deliver tech solutions that drive service efficiencies and improve treatment outcomes. “The SilverCloud platform has seen a significant increase in use since working with the HSE. Our ongoing collaboration with PCMIS will play a key role in maintaining the efficient delivery of services on the platform through this growth." said Elaine Martin, Director of SilverCloud Clinical Operations at Amwell.

COLLABORATION PARTNERSHIP

#institution

#cbt

View Analyst & Ambassador Comments
Go to original news
Dec 01,2023 TOP STORY

Lunit to Advance Singapore’s Healthcare Landscape with AI-powered Chest Screening Solution Integrated into National AI Platform

Lunit, , a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, has joined forces with NTT DATA Singapore to introduce Lunit INSIGHT CXR to Singapore’s public healthcare system. Following the agreement, Lunit successfully delivered Lunit INSIGHT CXR to NTT DATA, which, in turn, facilitated the delivery to Synapxe, Singapore’s national health-tech agency. Utilizing AimSG, Singapore’s national AI platform for medical imaging, Synapxe integrated Lunit INSIGHT CXR into the clinical radiology workflow of two leading public hospitals: Singapore General Hospital (SGH) and Changi General Hospital (CGH), each with over 1,000 beds. The AimSG platform is a collaboration amongst Synapxe, SingHealth, Lunit, NTT DATA, and its partners (DeepTek and CARPL), with support from Singapore’s Ministry of Health (MoH) and Smart Nation Singapore. AimSG facilitates seamless integration of AI imaging solutions, like Lunit INSIGHT CXR, into existing clinical radiology workflows.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Subscribe to INSTITUTION